Novartis, Takeda to enter next Medicare drug price negotiationsnews2026-02-27T19:43:29+00:00February 27th, 2026|Endpoints News|
CHMP recommends Moderna’s flu-Covid shot and Novartis pill for hivesnews2026-02-27T18:16:15+00:00February 27th, 2026|Endpoints News|
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the futurenews2026-02-27T12:11:21+00:00February 27th, 2026|Endpoints News|
DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case news2026-02-26T20:42:26+00:00February 26th, 2026|Endpoints News|
Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart news2026-02-26T20:17:18+00:00February 26th, 2026|Endpoints News|
FDA probes internal Prasad complaints with outside helpnews2026-02-26T20:13:02+00:00February 26th, 2026|Endpoints News|
Boehringer wins accelerated approval for first-line use of lung cancer drugnews2026-02-26T20:03:47+00:00February 26th, 2026|Endpoints News|
Viatris plans to lay off up to 10% of staff, discloses Indian factory fire news2026-02-26T18:09:12+00:00February 26th, 2026|Endpoints News|
Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drugnews2026-02-25T20:17:20+00:00February 25th, 2026|Endpoints News|
